Abstract:In the situation of Coronavirus disease 2019 (COVID-19), forecasting disease progression and identifying therapeutic drug targets is critical, especially given the nonattendance of a viable approach for treating severe cases. The preparation cohort revealed promising biomarkers, which were then precisely measured and employed to assess prediction accuracy across validation cohorts. This approach holds significant potential in enhancing understanding of severe COVID-19 and aiding the development of effective treatments. However, ultrasound-guided MRI (US-MRI) is an emerging modality that can noninvasively acquire multi-parametric information on COVID-19 and function without the need for contrast agents. This shows that neural network analysis of US-MRI transports exclusive prognosis data and this significantly improved prognosis performance. Consequently, the research proposed a deep neural network model of an Ensemble Multi-Relational Graph Neural Network (EMR-GNN) to determine the optimal model for predicting vascular biomarkers (CRP, IL-6, ferritin). In the nonappearance of a tailored treatment for this emerging virus, scientists are actively investigating various strategies to curb its replication. This work focuses on identifying potential drug targets, drawing from proteins abundant in lung material and those targeted by FDA-approved drugs as catalogued in HPA. This effort reflects a broader initiative within the methodical unrestricted to develop effective means of limiting virus replication. Accordingly, recognized five lung-improved proteins, comprising MRC1, SG3A1, CCL18, histone H4, and CLEC3B, were annotated as “drug targets”. For this, the researcher proposes a Heterogeneous Graph Structural Attention Neural Network (HGS-ANN) model to learn topological information of composite molecules and a Dilated Causal CNN-LSTM model with U-Net layers for modelling spatial-sequential information in Simplified Molecular-Input Line-Entry System (SMILES) sequences of drug data. The COVID-19 datasets are downloaded from the GEO database. These data are evaluated using Matlab software. The proposed work evaluated that the AUC of the work is 0.995, however, the AUC is measured based on sex, age, and chronic diseases. This model has a 0.933 accuracy in the subgroup of slices thicker than 1mm. However, the AUC curve and the classification outcome of the proposed method are compared with the existing rad model, deeper, and KNN models. In comparison to existing methods, the proposed model demonstrates superior performance. This research not only identifies potential therapeutic targets nonetheless also serves to uncover biomarkers crucial for comprehending the pathogenesis of undecorated COVID-19.

Multi-Modal Machine Learning Approach for COVID-19 Detection Using Biomarkers and X-Ray Imaging

CovidAID: COVID-19 Detection Using Chest X-Ray

Optimized COVID-19 detection using sparse deep learning models from multimodal imaging data

Artificial Neural Network-Based Deep Learning Model for COVID-19 Patient Detection Using X-Ray Chest Images

Multi-modal fusion of deep transfer learning based COVID-19 diagnosis and classification using chest x-ray images

Hybrid CNN and XGBoost Model Tuned by Modified Arithmetic Optimization Algorithm for COVID-19 Early Diagnostics from X-ray Images

AI-enabled case detection model for infectious disease outbreaks in resource-limited settings

Long-period fiber grating with multi resonant wavelengths fabricated by a CO2 laser for distributed sensing

Accurately Differentiating Between Patients With COVID-19, Patients With Other Viral Infections, and Healthy Individuals: Multimodal Late Fusion Learning Approach

[MRI: projectiles, bullets and counter-indications].

Deep Learning-Based System Combining Chest X-Ray and Computerized Tomography Images for COVID-19 Diagnosis

Machine Learning Automatically Detects COVID-19 using Chest CTs in a Large Multicenter Cohort

Multifaceted Disease Diagnosis: Leveraging Transfer Learning with Deep Convolutional Neural Networks on Chest X-Rays for COVID-19, Pneumonia, and Tuberculosis

Utilizing Deep Learning Models and Transfer Learning for COVID-19 Detection from X-Ray Images

Development and Validation of a Machine Learning Approach for Automated Severity Assessment of COVID-19 Based on Clinical and Imaging Data: Retrospective Study

CovMediScanX: A medical imaging solution for COVID-19 diagnosis from chest X-ray images

Advancing Diagnostic Precision: Leveraging Machine Learning Techniques for Accurate Detection of Covid-19, Pneumonia, and Tuberculosis in Chest X-Ray Images

A Prospective Observational Study to Investigate Performance of a Chest X-ray Artificial Intelligence Diagnostic Support Tool Across 12 U.S. Hospitals

Prediction of Covid-19 Multiparametric Biomarkers and Drug Target of Patients for Risk Stratification Using Machine Learning Approach

Multi-Scale CNN: An Explainable AI-Integrated Unique Deep Learning Framework for Lung-Affected Disease Classification

A novel hand-crafted with deep learning features based fusion model for COVID-19 diagnosis and classification using chest X-ray images